Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|May 15, 2015
Application of Physiologically Based Absorption Modeling for Amphetamine Salts Drug Products in Generic Drug EvaluationAndrew H Babiskin, Xinyuan ZhangMolecular Systems Biology|March 3, 2011
A synthetic library of RNA control modules for predictable tuning of gene expression in yeastAndrew H Babiskin, Christina D SmolkeNucleic Acids Research|March 1, 2011
Engineering ligand-responsive RNA controllers in yeast through the assembly of RNase III tuning modulesAndrew H Babiskin, Christina D SmolkeNucleic Acids Research|July 9, 2011
Synthetic RNA modules for fine-tuning gene expression levels in yeast by modulating RNase III activityAndrew H Babiskin, Christina D SmolkeCPT: Pharmacometrics & Systems Pharmacology|May 3, 2019
In Silico Methods for Development of Generic Drug-Device Combination Orally Inhaled Drug ProductsRoss L Walenga, Andrew H Babiskin, Liang ZhaoJournal of Pharmaceutical Sciences|November 3, 2018
Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup TimeRoss L Walenga, Andrew H Babiskin, Xinyuan Zhang, et al.Pharmaceutical Research|November 6, 2025
Using Lung Regional Deposition Modeling as Model-Integrated Evidence for Locally Acting Orally Inhaled Drug ProductsRoss L Walenga, Steven G Chopski, Jae H Lee, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2024
Nasal absorption of oxycodone predicted using a novel computational fluid dynamics-physiologically based pharmacokinetic modelRoss L Walenga, Andrew H Babiskin, Heather J Boyce, et al.The AAPS Journal|January 4, 2024
Use of the Same Model or Modeling Strategy Across Multiple Submissions: Focus on Complex Drug ProductsRoss L Walenga, Andrew H Babiskin, Sid Bhoopathy, et al.Pageof 1